Gene Query: ISOC2

Dataset Description Geneva Score
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 52.96
Genome wide expression change in LCC2 and MCF-7 cells 33.97
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 30.12
Gene expression profiling of leukemia cells following asparagine depletion 27.47
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 25.98
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 25.98
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 25.49
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 24.38
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 24.38
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 22.52
The comparison of high-throughput single-cell RNA-seq methods 20.56
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 19.91
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 19.74
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 19.16
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 18.62
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 16.04
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 15.93
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 15.93
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 15.66
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 15.09
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 15.01
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 14.83
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 14.67
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 14.66
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 14.58
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 14.43
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 14.3
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 14.3
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 14.22
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 14.14
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 14.13
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 14.12
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 14.0
RNAseq analysis of ESRP regulated splicing events in prostate cancer 13.47
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 13.32
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 13.24
Global analysis of enhancer targets: Mosaic-seq 12.96
Role for citron kinase in prostate cancer growth 12.88
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 12.7
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 12.69
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 12.55
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 12.55
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 11.94
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 11.9
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.89
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 11.75
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 11.71
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 11.65
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 11.59
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.29
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 11.24
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 11.17
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 11.15
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 11.09
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 11.06
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 11.06
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 10.92
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 10.89
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 10.7
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 10.7
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.64
Developmental stage specific chromosome architecture in human erythroid cells 10.5
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 10.5
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 10.49
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 10.45
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 10.42
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 10.41
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 10.41
Genome-wide identification of cancer-specific alternative splicing in circRNA 10.41
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 10.2
Identification of HOXB13 target genes responsive to BET inhibitors 10.07
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 10.04
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 9.76
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 9.7
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.69
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 9.68
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 9.63
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 9.47
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 9.45
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 9.41
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 9.16
scRNASeq analysis of cycling cardiomyocytes 9.13
TGF-β regulation of miRNA expression in pancreatic cancer 9.11
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 8.99
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 8.83
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 8.83
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 8.77
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 8.72
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.7
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 8.55
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 8.55
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 8.44
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 8.39
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 8.33
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 8.33
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 8.31
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 8.29
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 8.29
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 8.21
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 8.19
Spliceosomal disruption of the non-canonical BAF complex in cancer 8.17
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 8.14
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.14
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.14
Impact of dieldrin on transcription in Jurkat T cells 8.13
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 8.12
Transcriptome analysis of SKI knock-out in HL60 cells 8.1
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 8.1
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.09
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 8.03
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 7.84
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 7.79
RNA seq with AML (NB4) cells upon FTO inhibition 7.67
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.67
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.64
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 7.63
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 7.62
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 7.57
An RNA-centric dissection of host complexes controlling flavivirus infection 7.46
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 7.46
Evaluating pre-clinical models for studying NASH driven HCC. 7.45
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 7.45
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 7.45
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.44
Electronic cigarettes 7.43
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.39
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.38
A single cell reference map for human blood and tissue T cell activation 7.38
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 7.33
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.3
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 7.28
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 7.18
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 7.17
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 7.15
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.14
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.12
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 7.08
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.03
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.98
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.98
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.98
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 6.95
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 6.95
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 6.88
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.85
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 6.85
Seletive inhibition of CDK9 in DLBCL cell lines 6.82
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 6.74
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 6.74
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 6.71
RNA sequencing of primary human platelets and in vitro cell lines 6.7
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.66
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.63
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 6.44
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 6.41
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 6.4
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 6.37
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 6.34
RNA-seq analyses of human prostate cancer cells 6.31
CDK4/6 inhibitor resistance in prostate cancer 6.27
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 6.25
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 6.23
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 6.22
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.22
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.22
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 6.21
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 6.19
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 6.19
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 6.18
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 6.15
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.09
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.07
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 6.07
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 6.05
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 5.99
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.99
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 5.98
Loss of CREBBP results in gene expression repression in lymphoma cells 5.86
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 5.86
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 5.84
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 5.84
Iron response of HepG2 cells 5.82
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.81
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 5.78
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 5.78
DIGIT regulates endoderm differentiation of human embryonic stem cells 5.74
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 5.71
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 5.7
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.7
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 5.7
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 5.68
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.65
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.65
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 5.59
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.59
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 5.58
Chromatin landscape of human visceral and subcutaneous adipocytes 5.58
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.57
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.57
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.57
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.55
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 5.52
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 5.5
Paxillin regulates genomic networks in prostate cancer [LNCaP] 5.49
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 5.48
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 5.48
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.47
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.46
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 5.45
Discovering human diabetes-risk gene function with genetics and physiological assays 5.42
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 5.39
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.38
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 5.32
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.27
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 5.26
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 5.26
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.25
IDH3a KO RNA-seq 5.23
Gene expression profile difference among renal location in a stone former 5.23
High-throughput sequencing of pluripotent cells 5.23
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 5.22
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 5.2
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 5.2
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 5.19
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.18
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.16
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.16
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.1
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 5.09
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.06
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.06
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 4.99
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.99
RNAseq of cell lines with knocked in ESR1 mutations 4.97
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.96
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.91
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 4.9
Proteomics identifies a marker signature of MAPKi resistance in melanoma 4.87
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 4.86
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 4.84
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.82
RNA-seq of human fibroblasts after irradiation 4.82
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.81
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.73
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 4.67
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.66
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.65
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 4.64
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.63
JAK dependent survival of ALK- ALCL 4.53
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.51
RNAseq Study in CC-671 Treated Cal-51 Cells 4.44
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.44
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.41
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 4.35
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.33
NR2F2 study 4.29
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 4.29
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 4.29
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.29
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.28
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.25
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 4.2
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 4.19
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 4.19
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 4.19
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 4.19
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 4.19
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 4.19
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 4.16
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 4.16
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.06
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 4.03
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 4.03
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 4.03
Gene expression analysis of human hepatocellular cancers 4.02
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.01
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.0
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 3.96
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.91
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.9
Effect of PBK knockdown on C4-2 cell transcriptome 3.86
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.83
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.8
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.8
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.8
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.79
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 3.79
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 3.79
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 3.75
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.68
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.68
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.65
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 3.63
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.62
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.6
RNA editing in nascent RNA affects pre-mRNA splicing 3.54
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.49
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 3.48
Molecular analysis of renal cell carcinoma with unclassfied histology 3.48
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 3.48
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.46
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.42
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.38
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.26
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.26
TT-Seq captures the human transient transcriptome 3.23
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.23
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.22
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.22
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.22
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 3.22
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.21
KLF6-dependent transcription in renal cancer cells 3.19
Effect of CHKA knockdown on C4-2 cell transcriptome 3.18
Effect of PRDM11 depletion in U2932 cells 3.17
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.17
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.15
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 3.08
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 3.07
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.04
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.04
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 3.03
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.02
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 3.01
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 3.01
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.01
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.99
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 2.99
RNA-seq of naive and primed ES cells 2.91
The transcriptome effect of overexpressing EZH2 in MCF7 2.89
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.88
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 2.88
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 2.86
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 2.83
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 2.83
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.81
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.78
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.77
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.76
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.76
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 2.74
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.72
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.71
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.69
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.67
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.65
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.65
RNA-seq analysis of differentiating human erythroblasts 2.65
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.64
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.63
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.59
PRDM1 inhibits proliferation of human colon cancer organoids 2.59
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 2.54
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.51
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.49
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.46
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.46
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.45
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.43
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.43
Copper Regulation of HIF-1 Transcription Activity 2.43
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.42
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.33
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.32
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.29
RNA-seq analysis upon ARID1B overexpression 2.26
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.25
Hepatocyte maturation 2.25
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.23
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.22
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 2.21
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.21
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.21
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 2.2
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.2
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.16
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 2.12
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.11
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.08
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.08
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.05
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 2.01
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 2.01
Identification of long noncoding RNAs in T-ALL cell lines 1.96
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 1.96
AMPK signaling for naïve pluripotency 1.94
AMPK signaling for naïve pluripotency [Hs] 1.94
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.94
RNA-Seq of PRMT1 overexpression ECA109 cells 1.93
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.92
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.92
Effect of ILF3 on translation during homeostasis and the antiviral response 1.84
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.83
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.82
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.73
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 1.7
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.69
Transcriptome sequencing of K-562 cells 1.68
miRNAs affected by antagomiR-17 treatment 1.68
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.68
NAPRT activation of macrophages 1.67
RNA Seq of Alagille liver biopsies 1.64
Alagille_Nodder 1.64
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.64
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.62
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.58
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.58
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.55
Molecular Criteria for Defining the Naive Human Pluripotent State 1.54
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.54
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.53
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.47
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.47
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.47
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.42
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.4
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.39
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 1.36
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.32
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.3
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.26
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.24
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.23
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.2
Expression profiling of MCF-7 cells with treatment of TCDD 1.2
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.2
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.2
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.18
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 1.15
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.09
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.08
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.06
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.96
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.96
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.92
m6A-dependent regulation of messenger RNA stability 0.84
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.81
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.8
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.78
Ribosomal protein RPL26 is the principal target of UFMylation 0.77
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.76
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.75
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.75
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.72
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.65
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.65
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.62
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.57
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.57
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.53
Investigate A2M treatment on human prostate cancer and mouse liver 0.52
Investigate A2M treatment on human prostate cancer xenograft in mice 0.52
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 0.5
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.49
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.47
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.46
ChIP-seq and RNA-seq from human lymphoma cell lines 0.45
RNA-seq data from human lymphoma cell lines 0.45
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.43
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.33
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.32
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.32
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.31
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.31
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.27
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.25
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.24
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.24
The role of the Calcium-Sensing receptor in colorectal cancer 0.23
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.23
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.23
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.2
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.2
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.2
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.18
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.18
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.18
Macrophage Ad5f35 M2 Challenge 0.17
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.15
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.13
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.13
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.12
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.12
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.1
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.09
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.09
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.09
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.09
Impact on erythroid progenitor type on erythroid differntiation 0.08
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.05
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.04
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.04
RNA-Seq and expression data from human adipose tissue 0.02
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.02
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.01
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.0
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.0
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation